Back to Search
Start Over
Laparoscopically assisted versus open oesophagectomy for patients with oesophageal cancer-the Randomised Oesophagectomy: Minimally Invasive or Open (ROMIO) study: protocol for a randomised controlled trial (RCT).
- Source :
-
BMJ open [BMJ Open] 2019 Nov 19; Vol. 9 (11), pp. e030907. Date of Electronic Publication: 2019 Nov 19. - Publication Year :
- 2019
-
Abstract
- Introduction: Surgery (oesophagectomy), with neoadjuvant chemo(radio)therapy, is the main curative treatment for patients with oesophageal cancer. Several surgical approaches can be used to remove an oesophageal tumour. The Ivor Lewis (two-phase procedure) is usually used in the UK. This can be performed as an open oesophagectomy (OO), a laparoscopically assisted oesophagectomy (LAO) or a totally minimally invasive oesophagectomy (TMIO). All three are performed in the National Health Service, with LAO and OO the most common. However, there is limited evidence about which surgical approach is best for patients in terms of survival and postoperative health-related quality of life.<br />Methods and Analysis: We will undertake a UK multicentre randomised controlled trial to compare LAO with OO in adult patients with oesophageal cancer. The primary outcome is patient-reported physical function at 3 and 6 weeks postoperatively and 3 months after randomisation. Secondary outcomes include: postoperative complications, survival, disease recurrence, other measures of quality of life, spirometry, success of patient blinding and quality assurance measures. A cost-effectiveness analysis will be performed comparing LAO with OO. We will embed a randomised substudy to evaluate the safety and evolution of the TMIO procedure and a qualitative recruitment intervention to optimise patient recruitment. We will analyse the primary outcome using a multi-level regression model. Patients will be monitored for up to 3 years after their surgery.<br />Ethics and Dissemination: This study received ethical approval from the South-West Franchay Research Ethics Committee. We will submit the results for publication in a peer-reviewed journal.<br />Trial Registration Number: ISRCTN10386621.<br />Competing Interests: Competing interests: None declared.<br /> (© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ.)
- Subjects :
- Adenocarcinoma economics
Adenocarcinoma mortality
Adolescent
Adult
Aged
Aged, 80 and over
Carcinoma, Squamous Cell economics
Carcinoma, Squamous Cell mortality
Clinical Protocols
Cost-Benefit Analysis
Double-Blind Method
Esophageal Neoplasms economics
Esophageal Neoplasms mortality
Esophagectomy economics
Female
Follow-Up Studies
Humans
Male
Middle Aged
Neoplasm Recurrence, Local economics
Neoplasm Recurrence, Local epidemiology
Neoplasm Recurrence, Local etiology
Neoplasm Recurrence, Local prevention & control
Postoperative Complications economics
Postoperative Complications epidemiology
Postoperative Complications etiology
Quality of Life
Regression Analysis
Treatment Outcome
United Kingdom epidemiology
Young Adult
Adenocarcinoma surgery
Carcinoma, Squamous Cell surgery
Esophageal Neoplasms surgery
Esophagectomy methods
Laparoscopy economics
Subjects
Details
- Language :
- English
- ISSN :
- 2044-6055
- Volume :
- 9
- Issue :
- 11
- Database :
- MEDLINE
- Journal :
- BMJ open
- Publication Type :
- Academic Journal
- Accession number :
- 31748296
- Full Text :
- https://doi.org/10.1136/bmjopen-2019-030907